RIGEL PHARMACEUTICALS, INC. Shares Issued
RIGEL PHARMACEUTICALS, INC. (RIGL) had Shares Issued of 18.31 million shares as of 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-03-03
- 2025-12-31: Common Stock, Shares, Issued 18.31M shares.
- 2024-12-31: Common Stock, Shares, Issued 17.71M shares.
- 2023-12-31: Common Stock, Shares, Issued 17.48M shares; Common Stock, Shares, Issued as first filed 174.83M shares.
- 2022-12-31: Common Stock, Shares, Issued 173.40M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2025-12-31 | 18.31M shares 10-K · filed 2026-03-03 | |
| 2024-12-31 | 17.71M shares 10-K · filed 2026-03-03 | |
| 2023-12-31 | 17.48M shares 10-K · filed 2025-03-04 | 174.83M shares 10-K · filed 2024-03-05 |
| 2022-12-31 | 173.40M shares 10-K · filed 2024-03-05 | |
| 2021-12-31 | 171.60M shares 10-K · filed 2023-03-07 | |
| 2020-12-31 | 169.32M shares 10-K · filed 2022-03-01 | |
| 2019-12-31 | 167.99M shares 10-K · filed 2021-03-02 | |
| 2018-12-31 | 167.17M shares 10-K · filed 2020-02-27 | |
| 2017-12-31 | 146.81M shares 10-K · filed 2019-02-28 | |
| 2016-12-31 | 99.27M shares 10-K · filed 2018-03-06 | |
| 2015-12-31 | 90.55M shares 10-K · filed 2017-03-07 | |
| 2014-12-31 | 88.04M shares 10-K · filed 2016-03-08 | |
| 2013-12-31 | 87.52M shares 10-K · filed 2015-03-03 | |
| 2012-12-31 | 87.14M shares 10-K · filed 2014-03-04 | |
| 2012-09-30 | 71.76M shares 10-Q · filed 2012-11-06 | |
| 2012-06-30 | 71.60M shares 10-Q · filed 2012-08-07 | |
| 2012-03-31 | 71.45M shares 10-Q · filed 2012-05-01 | |
| 2011-12-31 | 71.38M shares 10-K · filed 2013-03-05 | |
| 2011-09-30 | 71.23M shares 10-Q · filed 2011-11-01 | |
| 2011-06-30 | 71.20M shares 10-Q · filed 2011-08-02 | |
| 2010-12-31 | 52.27M shares 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |